SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-019615
Filing Date
2020-09-02
Accepted
2020-09-02 07:00:17
Documents
2
Period of Report
2020-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10014849_8k.htm 8-K 20315
2 EXHIBIT 10.1 brhc10014849_ex10-1.htm EX-10.1 57529
  Complete submission text file 0001140361-20-019615.txt   79130
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 201155665
SIC: 2834 Pharmaceutical Preparations